Financial Performance - The estimated combined risk-based capital (RBC) ratio is between 405% and 425%[9, 32] - The holding company liquid assets are $0.9 billion[9, 31] - The statutory combined total adjusted capital (TAC) is $5.6 billion[9] - The year-to-date normalized statutory loss is $0.1 billion[9] - Adjusted earnings were $198 million, $60 million below expectations, primarily due to a lower alternative investment income yield of 1.5%[9] Segment Performance - Annuities adjusted earnings, less notable items, were $332 million, an increase of 8% compared to 2Q 2024[12, 69] - Life Insurance adjusted earnings, less notable items, were $(26) million[17, 69] - Run-off adjusted earnings (loss), less notable items, were $(83) million[23, 69] - Corporate & Other adjusted earnings (loss), less notable items, were $(25) million[25, 69] Investment Portfolio - Total investments are $127 billion[36] - Fixed maturity securities (FMS) are $87 billion, with 97% investment grade[36] - Commercial mortgage loan portfolio is $12.9 billion, representing 10% of total investments[40]

Q3 FY25 Financial Performance - Total company Book-to-bill was approximately 10, consistent with the normal historical range[7] - Reported sales increased by 5% year-over-year, with organic sales up over 4%[7] - Total Annual Recurring Revenue (ARR) grew by 7% year-over-year[7] - GAAP pretax margin was 160% and diluted EPS was $260[7] - Segment operating margin was 212% and Adjusted EPS was $282, exceeding expectations[7] - Achieved approximately $250 million in year-over-year productivity benefits, ahead of schedule[7] - Free Cash Flow was $489 million, compared to $238 million in Q3 FY24[14] Segment Performance - Discrete segment sales increased by approximately 10% organically, with Automotive up low teens and e-Commerce & Warehouse Automation up approximately 30%[8] - Software & Control segment sales increased by 23% due to 22% organic growth[15] - Lifecycle Services segment sales decreased by 6% organically[15] Regional Performance - North America is expected to be the strongest region in FY25, with Q3 FY25 organic sales growth of 7%[10, 11] - Latin America organic sales decreased by 14%[10] Full Year Outlook - Updated reported and organic sales growth range to (2)% to 1% year-over-year[13] - Adjusted EPS range updated to $980 - $1020[13] - Expect segment margin of approximately 20%, including over $250 million benefit from cost reduction and margin expansion actions[13] - Expect Free Cash Flow conversion of approximately 100%[13]

Core Insights - Steven Madden, Ltd. reported challenging financial results for Q2 2025, primarily due to new tariffs impacting imported goods [3][4][11] - The company is focused on long-term growth through strategic consumer engagement and the integration of Kurt Geiger, which is expected to drive future growth [3][4] Financial Performance - Total revenue for Q2 2025 increased by 6.8% to $559.0 million compared to $523.6 million in Q2 2024 [8] - Gross profit as a percentage of revenue decreased to 40.4% from 41.5% in the same period last year [8] - The company reported a net loss of $39.5 million, or $0.56 per diluted share, compared to a net income of $35.4 million, or $0.49 per diluted share, in Q2 2024 [8][27] Revenue Breakdown - Wholesale revenue was $360.6 million, a decrease of 6.4% year-over-year, with a 12.8% decline when excluding Kurt Geiger [4] - Direct-to-consumer revenue rose by 43.3% to $195.5 million, although it decreased by 3.0% when excluding Kurt Geiger [5] Operational Metrics - The company ended the quarter with 392 retail stores, including 98 outlets, and seven e-commerce websites [6] - Operating expenses as a percentage of revenue increased to 47.2% from 31.3% in Q2 2024 [8] Balance Sheet and Cash Flow - As of June 30, 2025, total debt was $293.5 million, with cash and short-term investments totaling $111.9 million, resulting in net debt of $181.6 million [9] - The company did not repurchase any shares during the quarter [9] Dividend Announcement - The Board of Directors approved a quarterly cash dividend of $0.21 per share, payable on September 23, 2025 [10] Future Outlook - Due to ongoing macroeconomic uncertainties related to tariffs, the company is not providing financial guidance for 2025 [11]

Core Viewpoint - Eagle Bancorp, Inc. held its Second Quarter 2025 Earnings Call, indicating a focus on financial performance amidst an uncertain market environment [1][2]. Financial Performance - The earnings release and related financial information will include non-GAAP financial metrics, which are essential for understanding the company's performance [4]. Risk Factors - The company highlighted that its Form 10-K for fiscal year 2024 and Form 10-Q for the quarter ended March 31, 2025, outline risk factors that could lead to actual results differing from forward-looking statements [3].

COVID-19 Impact and Response - The COVID-19 pandemic has had an unprecedented impact on commercial aviation, with passenger traffic down approximately 95%[9] - The airline industry is expected to experience a revenue decline of $314 billion (55%) in 2020 due to the pandemic[9] - Gogo expects its Commercial Aviation (CA) sales to be down 60-70% in April due to the impact of COVID-19[12] - Prior to cost reductions, Gogo CA was losing $1 million per day[12] - Gogo has developed flexible action plans with "16 Levers" to manage costs, tied to revenue projections based on various scenarios[20] Financial Performance and Refinancing - Gogo successfully refinanced $162 million in convertible debt and $690 million in senior secured notes, pushing 80% of maturities to 2024[26] - Gogo improved its free cash flow by $163 million, from -$214 million to -$51 million[28] - Cash flow from operating activities improved by $146 million, from -$82 million to $64 million[28] - Adjusted EBITDA improved 104% to $146 million from $71 million in 2018[30] - Net loss improved to -$146 million from -$162 million in 2018[30] Strategic Initiatives - Gogo launched its Gogo 5G project, which is on target for a 2021 launch[29] - Gogo is focused on continuing its drive to positive free cash flow and taking advantage of consolidation in the IFEC and Satellite industries[35]

Financial Performance - Q3 2019 - Total revenue grew to $128.2 million in Q3 2019, an increase of $20.6 million or 19% year-over-year from $107.6 million in Q3 2018[37] - Adjusted EBITDA reached $70.8 million, up from $61.9 million in the same quarter of 2018[37] - Commercial Services revenue was $77.6 million in Q3, an 8% increase year-over-year[29] - Government Solutions revenue was $50.6 million in Q3, a 42% increase year-over-year[29] Profitability & Margins - Commercial Services adjusted EBITDA was $51.1 million in Q3, a $1.7 million or 3% improvement year-over-year[29] - Government Solutions adjusted EBITDA was $19.8 million in Q3, a $7.2 million or 58% improvement year-over-year[29] - Pro Forma Adjusted EBITDA margin was 55%[32] Debt & Leverage - Net debt leverage decreased to 3.3x[36] Acquisition - Verra Mobility acquired Pagatelia to accelerate European expansion[13]

AUM and Flows - Ending AUM decreased to $1.54 trillion, a 2.2% decrease compared to the prior quarter and a 6.3% decrease compared to the prior year[8, 50] - Long-term net outflows were $26.2 billion[7] - Excluding Western Asset Management, long-term net inflows were $7.4 billion[7] - Alternatives fundraised $6.8 billion, with $6.1 billion in private market assets[7] - ETF experienced $4.1 billion of net flows, reaching a record high AUM of $37.0 billion[7] Financial Performance - Adjusted revenue was $1.61 billion, a 4% decrease compared to the prior quarter and a 3% decrease compared to the prior year[8, 55] - Adjusted operating income was $377.2 million, a 8.6% decrease from the prior quarter and a 10.1% decrease from the prior year[8, 39] - Adjusted net income was $254.4 million, a 20.6% decrease from the prior quarter and a 17% decrease from the prior year[8, 39] - Adjusted diluted EPS was $0.47, a 20.3% decrease from the prior quarter and a 16.1% decrease from the prior year[8, 39] - Adjusted effective fee rate was 38.3 bps, compared to 37.2 bps in the prior quarter and 38.5 bps in the prior year[8, 10] Capital Management - Total cash and investments were $6.1 billion as of March 31, 2025[48]

Company Overview - CareTrust REIT has expanded its portfolio to 249 net-leased healthcare properties across 32 states with 27,229 operating beds/units as of March 31, 2025 [15] - The company also holds 21 other real estate related investments tied to 113 healthcare properties across 17 states, consisting of 11,968 operating beds/units, and one financing receivable related to 46 properties in one state consisting of 3,820 operating beds/units [15] - As of March 31, 2025, the company's investments totaled $3,633 million across 408 properties with 43,017 operating beds/units in 34 states [19] Financial Performance - For the three months ended March 31, 2025, total revenues were $96621 thousand, including $71646 thousand in rental income and $2807 thousand in interest income from financing receivable [49] - Net income attributable to CareTrust REIT, Inc for the three months ended March 31, 2025, was $65802 thousand, or $035 per basic and diluted share [49] - Normalized FFO attributable to CareTrust REIT, Inc for the quarter ended March 31, 2025, was $77848 thousand, or $042 per share [50] - Normalized FAD attributable to CareTrust REIT, Inc for the quarter ended March 31, 2025, was $80800 thousand [51] Portfolio Composition and Diversification - As of March 31, 2025, skilled nursing facilities comprised 579% of the total investment in real estate properties, generating 592% of the total rent/interest with a current yield of 102% [33] - The Ensign Group is the largest tenant, accounting for 272% of total rent from net-leased assets [34] - California represents the largest geographic concentration, contributing 221% of total rent and interest [39] Debt and Capital Structure - As of March 31, 2025, total debt was $825 million, with a weighted average interest rate of 4698% [59] - The company has a $400 million senior unsecured notes payable at 3875% due in 2028 and $425 million outstanding on its unsecured revolving credit facility [59] - The company's consolidated leverage ratio was 209% as of March 31, 2025, well below the maximum requirement of 60% [64] Future Outlook - The company's full-year 2025 guidance for Normalized FFO is $169 to $173 per share and for Normalized FAD is $173 to $177 per share [65]

Financial Performance Highlights - Orders increased by 173% to $13156 million, with record aftermarket orders[11] - Record backlog reached $51436 million, exceeding $5 billion for the first time[11] - Sales increased by 53% to $10015 million, or 66% excluding foreign exchange impacts[11] - Adjusted operating income margin increased by 190bps to 199%[11] - Adjusted EBITDA increased by 89% to $2311 million[11] - Adjusted EBITDA margin increased by 80bps to 231%[11] Cash Flow and Capital Structure - Free cash flow was negative $801 million, compared to negative $1357 million in Q1 2024[18] - The company aims to generate over $550 million in free cash flow in 2025 to reduce net leverage to the target range of 20-25x[38] Segment Results - Cryo Tank Solutions orders decreased by 42% and sales decreased by 41%, but the adjusted operating income margin increased by 220bps to 127%[28] - Specialty Products orders increased by 246% and sales increased by 167%, with an adjusted operating income margin increase of 560bps to 189%[28] Outlook - The company projects revenue between $465 billion and $485 billion, adjusted EBITDA between $1175 billion and $1225 billion, and adjusted diluted earnings per share between $1200 and $1300 for 2025[37]

Financial Highlights - Consolidated Adjusted EBITDA reached $1.163 billion, exceeding the high end of the first quarter outlook[8] - Consolidated Adjusted EBITDA grew by 14%[8] - Consolidated Adjusted EBITDA margin was 22.3%[8] - Adjusted diluted EPS increased by 35%[8] Ambulatory (USPI) Performance - Adjusted EBITDA grew by 16%[8] - Same-facility revenue grew by 6.8%[10] - Adjusted EBITDA margin was 38.2%[10] - USPI Net Revenue 2025E Midpoint is $4.925 billion, with a CAGR of 14.7% from 2019[18] - USPI Adjusted EBITDA 2025E Midpoint is $1.950 billion, with a CAGR of 13.9% from 2019[19] Hospital Performance - Adjusted EBITDA, excluding divested hospitals, grew by 23%[8] - Same-hospital admissions grew by 4.4%[9] - Adjusted EBITDA margin was 17.5%[9] Full Year 2025 Outlook - Consolidated Adjusted EBITDA is projected to be between $3.975 billion and $4.175 billion[10, 11] - Net operating revenues are expected to be between $20.6 billion and $21.0 billion[11]